Mexico HLA Typing for Transplant Market (2025-2030)
The Mexico HLA Typing for Transplant Market was valued at $10.99 Million in 2025 and projected to reach to $12.76 Million by 2030, representing a compound annual growth rate of 3.0%. Mexico's HLA typing for transplant market is positioned for steady growth as the country strengthens its organ transplantation infrastructure and healthcare capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Mexico HLA Typing for Transplant Market Trends and Insights
- This moderate expansion reflects Mexico's developing healthcare infrastructure and increasing investment in organ transplantation programs.
- Mexico's market growth is driven by rising demand for organ transplants, improved diagnostic capabilities, and greater awareness of HLA compatibility testing among healthcare providers. The HLA typing market in Mexico remains smaller than global counterparts but demonstrates steady expansion as the country strengthens its transplant networks and laboratory capacity.
- Mexico's healthcare sector is gradually adopting advanced immunogenetic testing protocols to improve transplant outcomes and reduce rejection rates.
- Between 2025 and 2030, Mexico is expected to see incremental adoption of HLA typing technologies across major transplant centers, supported by government health initiatives and private sector investment in diagnostic infrastructure..
Key Market Statistics
- CAGR (2025-2030) 3.0% CAGR
- Market Size, 2025 ~USD 10.99 Million
- Forecast, 2030 ~USD 12.76 Million
- Country Mexico
Mexico HLA Typing for Transplant Market Overview
Market Valuation :
Mexico's HLA typing for transplant market is valued at USD 10.99 million in 2025, with steady growth projected through 2030.
Growth Trajectory :
The market is expected to reach USD 12.76 million by 2030, representing a 3.0% CAGR, reflecting moderate but consistent expansion in transplant diagnostics.
Healthcare Infrastructure Development :
Mexico's developing healthcare infrastructure and increased government investment in organ transplantation programs are driving market adoption of HLA typing technologies.
Transplant Demand Drivers :
Rising prevalence of chronic kidney disease, liver cirrhosis, and heart conditions in Mexico are fueling demand for organ transplants and associated HLA typing services.
Mexico HLA Typing for Transplant Market Dynamics
- Government initiatives to expand transplant programs, coupled with increasing awareness among healthcare providers, are creating favorable conditions for market expansion.
- The 3.0% CAGR reflects Mexico's gradual but consistent investment in advanced diagnostic technologies. Looking ahead, Mexico's market growth will be supported by rising organ transplant volumes, improved laboratory standardization, and enhanced access to HLA typing services across major medical centers.
- However, growth remains moderate compared to global rates, indicating opportunities for market penetration and technology adoption as healthcare systems modernize and transplant programs expand nationwide..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Mexico's HLA typing market is valued at USD 10.99 million in 2025 and will reach USD 12.76 million by 2030 at a 3.0% CAGR.
- Mexico's market growth is driven by increasing organ transplant demand and improved laboratory infrastructure across major medical centers.
- Mexico's adoption of HLA typing technologies is supported by government health initiatives and private sector investment in diagnostic capabilities.
- Mexico's transplant sector is gradually modernizing immunogenetic testing protocols to enhance transplant outcomes and reduce rejection rates.
HLA Typing for Transplant Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | INDEPENDENT REFERENCE LABORATORIES (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | DIAGNOSTIC APPLICATIONS (Application) |
| Market Size Base Year (Billions) | ~USD 1.05 (2025) |
| Revenue Forecast (Billions) | ~USD 1.4 (2030) |
| Segments Covered | Product & Service, Technology, Type, Application, Transplant Type, End User |
Mexico HLA Typing for Transplant Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents & Consumables
- Software & Services
By Technology
- Molecular Assays
- Non-Molecular Assays
By Type
- Antibody Screening
- Chimerism Monitoring
- Next-Generation Sequencing
- Other Diagnostic Applications
- Other Pcr-Based Molecular Assays
- Other Sequencing-Based Molecular Assays
- Pcr-Based Molecular Assays
- Real-Time Pcr
- Sanger Sequencing
- Sequence-Specific Oligonucleotide-Pcr
- Sequence-Specific Primer-Pcr
- Sequencing-Based Molecular Assays
By Application
- Diagnostic Applications
- Research Applications
By Transplant Type
- Soft-Tissue Transplants
- Solid Organ Transplants
- Stem Cell Transplants
By End User
- Hospitals & Transplant Centers
- Independent Reference Laboratories
- Research Laboratories & Academic Institutes
Target Audience
- Diagnostic Equipment Manufacturers : Need Mexico market data to evaluate market size, growth potential, and competitive opportunities for HLA typing platforms and laboratory automation solutions.
- Healthcare Service Providers : Require market insights to assess demand for HLA typing services, plan transplant program expansion, and make informed decisions about diagnostic capability investments.
- Medical Laboratory Operators : Seek Mexico-specific forecasts to guide laboratory expansion, technology adoption, and service portfolio development in the transplant diagnostics segment.
- Healthcare Investors and Consultants : Need comprehensive Mexico market analysis to evaluate investment opportunities, assess market viability, and develop strategic recommendations for healthcare stakeholders.
- Government and Policy Makers : Require market data to inform healthcare policy decisions, transplant program funding, and infrastructure development initiatives aligned with market growth projections.
Key Companies in the Mexico HLA Typing for Transplant Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Instruments,Reagents,Software, |
| QUIDEL CORPORATION | United States | Public Company | Instruments (Transfusion & Molecular Platforms used in HLA/compatibility workflows),Reagents & Consumables (Antibody Screening, Donor Typing, Molecular Assays),Software & Informatics, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | PCR-based HLA typing (SSO, SSP, Real-time),NGS-based HLA typing,Sanger-based HLA typing, |
| ILLUMINA, INC. | United States | Public Company | NGS instruments,NGS reagents and consumables,Software and DRAGEN-based analysis, |
| QIAGEN | Netherlands | Public Company | Reagents & Assays (PCR, NGS, Sanger HLA, immune response),Instruments (PCR, NGS, sample prep, QC),Software & Bioinformatics (HLA typing, chimerism, data analysis), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Instruments (PCR, real-time, supporting platforms),Reagents & consumables for HLA typing and chimerism,Software & informatics for transplant workflows, |
| CAREDX, INC. | United States | Public Company | PCR-based HLA typing (SSO, SSP, Real-time),NGS-based HLA typing (AlloSeq Tx and related),Sanger-based HLA typing, |
| DIASORIN S.P.A. | Italy | Public Company | Reagents and assays (HLA-related and transplant-adjacent),Instruments and platforms (LIAISON, Simplexa, xMAP-based systems),Software and informatics for transplant workflows, |
| BECTON, DICKINSON AND COMPANY | United States | ||
| EUROBIO SCIENTIFIC | France | Public Company | Reagents (PCR, NGS, Sanger),Software (HLA typing, data analysis),Instruments and related hardware, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a large private healthcare services company founded in 1985 in the United States, employing 64,200 people. The company operates across multiple healthcare service segments.
QUIDEL CORPORATION
Quidel Corporation is a publicly traded diagnostic company founded in 1979 in the United States with 6,500 employees. The company develops and manufactures rapid diagnostic testing solutions.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a large publicly traded life sciences company founded in 1956 in the United States with 125,000 employees. The company provides laboratory equipment, reagents, and analytical instruments globally.
ILLUMINA, INC.
Illumina, Inc. is a publicly traded genomics company founded in 1998 in the United States with 8,625 employees. The company develops and manufactures DNA sequencing and genetic analysis systems.
QIAGEN
QIAGEN is a publicly traded molecular diagnostics company founded in 1984 in the Netherlands with 5,500 employees. The company provides sample and assay technologies for molecular testing.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a publicly traded life sciences company founded in 1952 in the United States with 7,450 employees. The company manufactures and distributes clinical diagnostic products and laboratory reagents.
CAREDX, INC.
CareDx, Inc. is a publicly traded molecular diagnostics company founded in 1998 in the United States with 763 employees. The company specializes in transplant diagnostics and precision medicine solutions.
DIASORIN S.P.A.
DiaSorin S.p.A. is a publicly traded Italian diagnostics company founded in 1968 with 3,242 employees. The company specializes in immunodiagnostic and molecular diagnostic products.
BECTON, DICKINSON AND COMPANY
Insufficient data provided for company description.
EUROBIO SCIENTIFIC
Eurobio Scientific is a publicly traded French diagnostics company founded in 1997 with 343 employees. The company develops and distributes in vitro diagnostic products.
Reasons to Buy this Report
- Mexico-Specific Market Sizing : Obtain precise valuation data for Mexico's HLA typing market with accurate 2025-2030 forecasts, enabling targeted investment and expansion strategies in this developing healthcare segment.
- Growth Opportunity Assessment : Understand Mexico's 3.0% CAGR trajectory and identify expansion opportunities within the country's growing organ transplantation infrastructure and diagnostic service demand.
- Competitive Landscape Intelligence : Gain insights into Mexico's healthcare provider ecosystem, laboratory capabilities, and market dynamics to inform product positioning and market entry strategies.
- Regulatory and Infrastructure Context : Access analysis of Mexico's healthcare regulations, transplant program development, and infrastructure investments that directly impact HLA typing service adoption and market growth.
- Strategic Decision Support : Leverage Mexico-focused market data to support business decisions regarding partnerships, facility development, technology deployment, and resource allocation in this emerging market.
Frequently asked questions
What is the current market size of HLA typing for transplants in Mexico?
Mexico's HLA typing for transplant market is valued at USD 10.99 million in 2025.
What is the projected market size for HLA typing in Mexico by 2030?
Mexico's HLA typing market is projected to reach USD 12.76 million by 2030.
What is the growth rate of Mexico's HLA typing market?
Mexico's HLA typing market is expected to grow at a compound annual growth rate of 3.0% from 2025 to 2030.
What factors are driving growth in Mexico's HLA typing market?
Mexico's market growth is driven by rising organ transplant demand, improved diagnostic infrastructure, increased healthcare provider awareness, and government investment in transplant programs.
How does Mexico's HLA typing market compare to global trends?
Mexico's 3.0% CAGR is more conservative than the global 6.0% CAGR, reflecting Mexico's developing healthcare infrastructure and gradual adoption of advanced immunogenetic testing technologies.
RESEARCH METHODOLOGY
This study analyzed market variables related to small and medium-sized businesses and major corporations to balance primary and secondary research for the human leukocyte antigen (HLA) typing for transplant market. The next phase involved conducting primary research with industry experts along the value chain to validate the findings, assumptions, and market sizing. Several methodologies were employed to estimate the overall market size, including both top-down and bottom-up approaches. This study focuses on key market segments, emerging trends, regulatory frameworks, and competitive environments. It also examines leading market players and their strategies within this sector. In conclusion, the total market size was determined using top-down and bottom-up approaches and data triangulation to arrive at the final figure. Ongoing primary research was conducted throughout the study to validate and test each hypothesis.
Secondary Research
During the study, secondary research utilized a variety of sources, including directories and databases such as Bloomberg Businessweek, D&B Hoovers, and Factiva. Additional materials included white papers, annual reports, SEC filings, and investor presentations. This research approach collects and generates data that offers comprehensive, technical, and market-focused insights into the HLA typing for transplant market. The data provides information on key players and market segmentation based on recent industry trends and significant market developments. Additionally, a database of leading industry figures was created through this secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the HLA typing for transplant market. The primary sources from the demand side include medical OEMs, CDMOs, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*Others include distributors, suppliers, product managers, business development managers, marketing managers, and sales managers.
Note: Companies are categorized into tiers based on their total revenue. As of 2024, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
In this report, the global HLA typing for transplant market size was arrived at by using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the HLA typing for transplants business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and marketing executives.
Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:
- Generating a list of major global players/OEMs operating in the HLA typing for transplant market
- Mapping the annual revenue generated by major global players from the HLA typing segment (or the nearest reported business unit/product category)
- Revenue mapping of top players to cover at least ~75% of the global market share as of 2024
- Extrapolation of the revenue mapping of major players to derive the global value of the market
- Extrapolating the global value of the HLA typing for transplant market.
- Summation of market value for all segments and subsegments to achieve the actual value of the global HLA typing for transplant market
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the global HLA typing for transplant market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, top-down and bottom-up approaches validated the HLA typing for transplant market.
Market Definition
HLA typing assays are critical in transplant immunology, as they facilitate the identification of HLA antigens essential for assessing donor-recipient compatibility and mitigating the risk of alloimmune rejection. These assays are pivotal in donor-recipient cross-matching, subject profiling, genotyping, and various diagnostic applications. Recent advancements in HLA typing technology, which enable high-resolution typing, afford precise delineation of HLA allele variations. This increased accuracy significantly enhances the predictive capability for transplant outcomes, thereby minimizing rejection and graft-versus-host disease incidence. As a result, these innovations are instrumental in making transplantation a more feasible and successful therapeutic option for patients.
Stakeholders
- Manufacturers of HLA typing products for transplant
- Distributors & suppliers of HLA typing products for transplant
- Hospitals, Transplant Centers, reference laboratories, Cord Blood Banks
- Research Laboratories and Academic Institutes
- Organ Procurement Organizations (OPOs)
- Non-government organizations
- Government regulatory authorities
- Contract manufacturers and third-party suppliers
- Clinical research organizations (CROs)
- Government and non-governmental regulatory authorities
- Market research and consulting firms
Report Objectives
- To define, describe, and forecast the HLA typing for transplant market based on product & service, technology, application, transplant type, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global HLA typing for transplant market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global HLA typing for transplant market
- To provide an average selling price trend for the target product categories in HLA typing for transplant market
- To analyze key growth opportunities in the global HLA typing for transplant market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa
- To profile the key players in the global HLA typing for transplant market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global HLA typing for transplant market, such as product launches, agreements, expansions, and acquisitions
Get the Full HLA Typing for Transplant Market Report
Full forecast, segment splits, and company analysis for all HLA Typing for Transplant Market.
- US HLA Typing for Transplant Market
- Canada HLA Typing for Transplant Market
- Germany HLA Typing for Transplant Market
- UK HLA Typing for Transplant Market
- France HLA Typing for Transplant Market
- Spain HLA Typing for Transplant Market
- Italy HLA Typing for Transplant Market
- China HLA Typing for Transplant Market
- India HLA Typing for Transplant Market
- Japan HLA Typing for Transplant Market
- Australia HLA Typing for Transplant Market
- South Korea HLA Typing for Transplant Market
- Brazil HLA Typing for Transplant Market
- Rest Of Europe HLA Typing for Transplant Market
- Rest Of Asia Pacific HLA Typing for Transplant Market
- Rest Of Latin America HLA Typing for Transplant Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
